To help people harmed by shots, Congress created the National Vaccine Injury Compensation Program. Government doctors and lawyers review claims. If they believe it is more likely than not that a vaccine — and not something else — caused the injury, they tap a $3.5 billion fund to pay for future care and lost wages. That fund is replenished by a 75-cent tax on each vaccine.
A surgeon who contracted Ebola in his native Sierra Leone received aggressive treatment at a Nebraska hospital over the weekend but died Monday morning. Dr. Martin Salia's death is a reminder of how deadly the Ebola virus is and how important it is to receive treatment early, said Dr. Jeff Gold, chancellor of the University of Nebraska Medical Center in Omaha.
Actavis will pay $66 billion to buy fellow drugmaker Allergan in a deal that could finally stop a months-long takeover push from Valeant Pharmaceuticals for the Botox maker.
Federal drug enforcement agents showed up unannounced Sunday to check at least three visiting NFL teams' medical staffs as part of an investigation into former players' claims that teams mishandled prescription drugs.
Zoetis today announced an agreement to purchase animal health assets of Abbott for a purchase price of $255 million. Abbott Animal Health is a companion animal health business focused on the veterinary surgical suite.
Bristol-Myers Squibb Company has announced plans to construct a new state-of-the-art, large-scale biologics manufacturing facility in Cruiserath, County Dublin, Ireland, that will produce multiple therapies for the company’s growing biologics portfolio.
A proposed global emergency fund to contain the next Ebola outbreak would also provide an incentive for drug companies to develop vaccines to fight other future pandemics, World Bank President Jim Yong Kim said Friday.
Press Trust of India reported that Ramesh Mahawar of Mahawar Pharma Pvt Ltd and his son were arrested and charged with fraud. Police Superintendent O.P. Pal told PTI that the men were arrested on the complaint of food and drug administration officials.
Kentucky is dropping its proposed use of a two-drug execution method after the prolonged deaths of inmates in two other states that used a similar means to carry out death sentences.
The U.S. Food and Drug Administration has approved Lemtrada, a treatment for relapsing multiple sclerosis made by the drugmaker Genzyme. The drug has already been approved by the European Medicines Agency for use in the European Union and in Canada and Australia.
Merck announced today that it has entered into a global agreement with Pfizer to co-develop and co-commercialize MSB0010718C, an investigational anti-PD-L1 antibody currently in development by Merck as a potential treatment for multiple tumor types to accelerate the two companies’ presence in immuno-oncology.
Shares of Allergan jumped in premarket trading Monday after several reports surfaced over the weekend that specialty drugmaker Actavis was preparing to buy the maker of Botox, which is embroiled in a takeover battle with Valeant Pharmaceuticals.
Purdue Pharma L.P. today announced that Gail Cawkwell, MD, PhD, former Vice President in the Medicines Development Group at Pfizer, has joined the company as Vice President of Medical Affairs.
Zoetis Inc. said Friday that it has adopted a one-year shareholder rights plan. These plans, often known as "poison pills", are intended to fight off hostile takeovers. Zoetis said the plan would enable existing shareholders a right to buy preferred stock if a person or group acquires at least 15 percent of the company's stock and tries to buy more.
Join Pharmaceutical Processing and Interphex for Interphex Live, a premier technology event that will be broadcast live on the INTERPHEX 2015 show floor. Interphex Live will feature discussions with the industry's leaders on topics including Biopharmaceutical Processing, Solid Dosage Manufacturing, Parenteral Processing, Regulatory Compliance, Inspection & Packaging, Supply Chain, Facility Design & Management and more.